We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Virtual Medical International Inc (CE) | USOTC:QEBR | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 00:00:00 |
[X]
|
QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2011
|
OR
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Large Accelerated Filer
|
[ ]
|
Accelerated Filer
|
[ ]
|
||
Non-accelerated Filer
|
[ ]
|
Smaller Reporting Company
|
[X]
|
||
(Do not check if smaller reporting company)
|
Page
|
|||
|
|||
|
|||
Financial Statements.
|
3
|
||
|
|||
Balance Sheet
s
(Unaudited)
|
F-1
|
||
Statements of Expenses
(Unaudited)
|
F-2
|
||
Statements of Cash Flows
(Unaudited)
|
F-3
|
||
Notes to Financial Statements
(Unaudited)
|
F-4
|
||
|
|||
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
8
|
||
|
|||
Quantitative and Qualitative Disclosures About Market Risk.
|
9
|
||
|
|||
Controls and Procedures.
|
9
|
||
|
|||
|
|||
Risk Factors.
|
10
|
||
|
|||
Other Information.
|
10
|
||
|
|||
Exhibits.
|
10
|
||
|
|||
11
|
|||
|
|||
12
|
June 30,
|
December 31,
|
|||
2011
|
2010
|
|||
ASSETS
|
||||
CURRENT ASSETS
|
||||
Cash
|
$
|
361
|
$
|
100
|
Total Current Assets
|
361
|
100
|
||
Other Assets
|
||||
Investment in securities available for sale, (net of market adjustment
of $5,544,000 and 4,620,000 respectively)
|
252,000
|
1,176,000
|
||
Total Other Assets
|
252,000
|
1,176,000
|
||
Total Assets
|
$
|
252,361
|
$
|
1,176,100
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||
CURRENT LIABILITIES:
|
||||
Accounts payable
|
$
|
45,363
|
$
|
21,661
|
Note payable - related party
|
54,553
|
19,567
|
||
Total Current Liabilities
|
99,916
|
41,228
|
||
Stockholders’ Equity
|
||||
Preferred stock, $.00001 par, 50,000,000 shares authorized,
44,479,500 shares issued and outstanding
|
445
|
445
|
||
Common stock, $.00001 par, 250,000,000 shares authorized
25,367,541 shares issued and outstanding, respectively
|
254
|
254
|
||
Additional paid-in capital
|
83,291,570
|
83,291,570
|
||
Accumulated other comprehensive (loss)
|
(5,544,000)
|
(4,620,000)
|
||
Deficit accumulated during the development stage
|
(77,595,824)
|
(77,537,397)
|
||
Total Stockholders’ Equity
|
152,445
|
1,134,872
|
||
Total Liabilities and Stockholders’ Equity
|
$
|
252,361
|
$
|
1,176,100
|
From Inception
|
||||||||||
(July 19, 2007)
|
||||||||||
Three Months Ended
|
Six Months Ended
|
Through
|
||||||||
June 30,
|
June 30,
|
June 30,
|
||||||||
2011
|
2010
|
2011
|
2010
|
2011
|
||||||
INCOME:
|
260
|
-
|
260
|
-
|
260
|
|||||
OPERATING EXPENSES:
|
||||||||||
Legal fees
|
$
|
8,380
|
$
|
11,788
|
$
|
12,994
|
$
|
12,898
|
$
|
89,850
|
Accounting fees
|
12,210
|
8,589
|
20,765
|
12,089
|
66,141
|
|||||
Office expense
|
131
|
280
|
131
|
946
|
6,239
|
|||||
Interest expense
|
123
|
-
|
123
|
-
|
123
|
|||||
License and fees
|
44
|
1,579
|
7,060
|
2,581
|
12,968
|
|||||
Consulting
|
15,325
|
1,790
|
15,325
|
2,965
|
42,274,374
|
|||||
Travel
|
-
|
1,605
|
-
|
1,606
|
2,315
|
|||||
Product development costs
|
-
|
-
|
-
|
-
|
25,271
|
|||||
Website
|
2,289
|
-
|
2,289
|
-
|
2,289
|
|||||
Loss on disposal of inventory
|
-
|
-
|
-
|
-
|
14,114
|
|||||
Total operating expenses
|
38,502
|
25,631
|
58,687
|
33,085
|
42,493,684
|
|||||
OPERATING LOSS
|
(38,242)
|
(25,631)
|
(58,427)
|
(33,085)
|
(42,493,424)
|
|||||
IMPAIRMENT ON LONG LIVED
ASSET
|
-
|
-
|
-
|
-
|
(35,102,400)
|
|||||
NET LOSS BEFORE OTHER
COMPREHENSIVE LOSS
|
(38,242)
|
(25,631)
|
(58,427)
|
(33,085)
|
(77,595,824)
|
|||||
OTHER COMPREHENSIVE LOSS
|
||||||||||
Unrealized loss in investments
available for sale
|
(252,000)
|
-
|
(924,000)
|
-
|
(5,544,000)
|
|||||
Total comprehensive loss
|
(252,000)
|
-
|
(924,000)
|
-
|
(5,544,000)
|
|||||
NET LOSS
|
$
|
(290,242)
|
$
|
(25,631)
|
$
|
(982,427)
|
$
|
(33,085)
|
$
|
(83,139,824)
|
Weighted average number of shares
|
14,453,953
|
7,832,363
|
14,453,953
|
7,347,624
|
||||||
Basic net loss per share
|
$
|
(0.02)
|
$
|
(0.00)
|
$
|
(0.07)
|
$
|
(0.00)
|
From Inception
|
|||||||||
(July 19, 2007)
|
|||||||||
Six Months Ended
|
Through
|
||||||||
June 30,
|
June 30,
|
||||||||
2011
|
2010
|
2011
|
|||||||
Cash Flows From Operating Activities
|
|||||||||
Net Loss
|
$
|
(58,427)
|
$
|
(33,085)
|
$
|
(77,595,824)
|
|||
Adjustments to reconcile net loss to net cash
|
|||||||||
used in operating activities:
|
|||||||||
Common stock issued for services
|
-
|
1,500
|
42,261,094
|
||||||
Impairment of long lived asset
|
-
|
-
|
35,102,400
|
||||||
Changes in assets and liabilities:
|
|||||||||
Prepaid expenses
|
-
|
(14,114)
|
142
|
||||||
Accounts payable
|
23,702
|
2,172
|
45,221
|
||||||
Total cash used in operating activities
|
(34,725)
|
(43,527)
|
(186,967)
|
||||||
Cash Flows From Financing Activities
|
|||||||||
Sale of common stock to founder
|
-
|
-
|
3,775
|
||||||
Notes payable - related party
|
34,986
|
-
|
54,553
|
||||||
Proceeds from sale of common stock
|
-
|
-
|
129,000
|
||||||
Total cash provided by financing activities
|
34,986
|
-
|
187,328
|
||||||
Net Increase (Decrease) in Cash
|
261
|
(43,527)
|
361
|
||||||
Cash at Beginning of Period
|
100
|
48,253
|
-
|
||||||
Cash at End of Period
|
$
|
361
|
$
|
4,726
|
$
|
361
|
|||
Supplemental Disclosure of Cash Flow Information
|
|||||||||
Interest paid
|
$
|
-
|
$
|
-
|
$
|
31
|
|||
Income taxes paid
|
$
|
-
|
$
|
-
|
$
|
-
|
|||
Non- Cash transactions from investing and financing activities
|
|||||||||
Asset purchase agreement
|
$
|
-
|
$
|
-
|
$
|
5,796,000
|
|||
Mark to market AFSS
|
$
|
924,000
|
$
|
-
|
$
|
5,292,000
|
|||
Acquisition of subsidiary
|
$
|
-
|
$
|
-
|
$
|
35,102,165
|
Payments due by periods
|
|||||
Obligations
|
Total
|
Less than
|
1-3 Years
|
3-5 Years
|
More than
|
1 year
|
5 years
|
||||
Long-Term Debt Obligations
|
-0-
|
-0-
|
-0-
|
-0-
|
-0-
|
Capital (Finance) Lease Obligations
|
-0-
|
-0-
|
-0-
|
-0-
|
-0-
|
Operating Lease Obligations
|
-0-
|
-0-
|
-0-
|
-0-
|
-0-
|
Purchase Obligations
|
-0-
|
-0-
|
-0-
|
-0-
|
-0-
|
Other Long Term Liabilities
|
-0-
|
-0-
|
-0-
|
-0-
|
-0-
|
Total
|
-0-
|
-0-
|
-0-
|
-0-
|
-0-
|
-
|
The Company lacks proper segregation of duties. We believe that the lack of proper segregation of duties is due to our limited resources.
|
-
|
The Company does not have a comprehensive and formalized accounting and procedures manual.
|
Incorporated by reference
|
|||||
Exhibit
|
Document Description
|
Form
|
Date
|
Number
|
Filed herewith
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/16/09
|
3.1
|
|
3.2
|
Bylaws.
|
S-1
|
3/16/09
|
3.2
|
|
4.1
|
Specimen Stock Certificate.
|
S-1
|
3/16/09
|
4.1
|
|
10.1
|
Consulting Agreement – Greg Ruff
|
8-K
|
9/16/10
|
10.1
|
|
10.2
|
Consulting Agreement – Robert Tassinari
|
8-K
|
9/16/10
|
10.2
|
|
10.3
|
Agreement with Entertainment Arts Research
|
8-K
|
9/16/10
|
10.1
|
|
10.4
|
Agreement with Entertainment Arts Research
|
8-K
|
12/10/10
|
10.1
|
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
99.1
|
Audit Committee Charter.
|
10-K
|
4/12/10
|
99.1
|
|
99.2
|
Disclosure Committee Charter.
|
10-K
|
4/12/10
|
99.2
|
VIRTUAL MEDICAL INTERNATIONAL, INC.
|
||
(the “Registrant”)
|
||
BY:
|
FRANCIS D’AMBROSIO
|
|
Francis D’Ambrosio
|
||
Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
|
Incorporated by reference
|
|||||
Exhibit
|
Document Description
|
Form
|
Date
|
Number
|
Filed herewith
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/16/09
|
3.1
|
|
3.2
|
Bylaws.
|
S-1
|
3/16/09
|
3.2
|
|
4.1
|
Specimen Stock Certificate.
|
S-1
|
3/16/09
|
4.1
|
|
10.1
|
Consulting Agreement – Greg Ruff
|
8-K
|
9/16/10
|
10.1
|
|
10.2
|
Consulting Agreement – Robert Tassinari
|
8-K
|
9/16/10
|
10.2
|
|
10.3
|
Agreement with Entertainment Arts Research
|
8-K
|
9/16/10
|
10.1
|
|
10.4
|
Agreement with Entertainment Arts Research
|
8-K
|
12/10/10
|
10.1
|
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
99.1
|
Audit Committee Charter.
|
10-K
|
4/12/10
|
99.1
|
|
99.2
|
Disclosure Committee Charter.
|
10-K
|
4/12/10
|
99.2
|
1 Year Virtual Medical (CE) Chart |
1 Month Virtual Medical (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions